BUDGET IMPACT ANALYSIS OF APREMILAST IN PATIENTS WITH PSORIASIS IN THE ITALIAN SETTING

被引：0
|
作者：
Barbieri, M. [1 ]
Capri, S. [2 ]
Oskar, B. [3 ]
机构：
[1] Univ York, Ctr Hlth Econ, York, N Yorkshire, England
[2] Cattaneo LIUC Univ, Sch Econ & Management, Castellanza, Italy
[3] Celgene Corp, Milan, Italy
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.560
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS36
引用
下载
收藏
页码：A421 / A421
页数：1
相关论文
共 50 条
  • [21] PROPEL® TECHNOLOGY - A BUDGET IMPACT ANALYSIS IN THE ITALIAN CONTEXT
    Borghetti, F.
    Tito, F.
    Corbo, M.
    VALUE IN HEALTH, 2023, 26 (12) : S134 - S134
  • [22] Budget impact analysis of infliximab biosimilar: the Italian scenery
    Lucioni, Carlo
    Mazzi, Silvio
    Caporali, Roberto
    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2015, 2 (02) : 78 - 88
  • [23] Cost-utility and budget impact analysis of adding-on apremilast to biologic therapy in the treatment of moderate to severe plaque psoriasis, an Iranian payer perspective
    Zargaran, Marzieh
    Soleymani, Fatemeh
    Nasrollahi, Saman Ahmad
    Seyedifar, Meysam
    Rahaghi, Mohammad Mehdi Ashrafian
    RESEARCH IN PHARMACEUTICAL SCIENCES, 2021, 16 (04) : 381 - 390
  • [24] Apremilast as a Potential Targeted Therapy for Metabolic Syndrome in Patients with Psoriasis: An Observational Analysis
    Campione, Elena
    Zarabian, Nikkia
    Cosio, Terenzio
    Borselli, Cristiana
    Artosi, Fabio
    Cont, Riccardo
    Sorge, Roberto
    Shumak, Ruslana Gaeta
    Costanza, Gaetana
    Rivieccio, Antonia
    Gaziano, Roberta
    Bianchi, Luca
    PHARMACEUTICALS, 2024, 17 (08)
  • [25] BUDGET IMPACT ANALYSIS OF THE USE OF DACLATASVIR FOR THE TREATMENT OF HEPATITIS C VIRUS (HCV) GENOTYPES 3, IN THE ITALIAN SETTING
    Restelli, U.
    Bonfanti, M.
    Alberti, A.
    Lazzarin, A.
    Nappi, C.
    Croce, D.
    VALUE IN HEALTH, 2015, 18 (07) : A580 - A580
  • [26] Repy to: "Comment on 'Drug survival of apremilast for psoriasis in a real-world setting'"
    Lee, Erica B.
    Amin, Mina
    Wu, Jashin J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (04) : E85 - E85
  • [27] Retrospective study of apremilast drug survival in psoriasis patients in a daily practice setting: A long-term experience
    Galache-Osuna, Cristina
    Reyes-Garcia, Sebastian
    Salgueiro, Esther
    Bordallo-Landa, Javier
    Lozano, Ana
    Vazquez-Lopez, Francisco
    Santos-Juanes, Jorge
    DERMATOLOGIC THERAPY, 2022, 35 (07)
  • [28] BARICITINIB IN ALOPECIA AREATA: A BUDGET IMPACT ANALYSIS IN SAUDI SETTING
    Alshahrani, A.
    Al-Aqeel, S.
    Alhawashi, S. T.
    Al-Nasser, M. S.
    Zaitoun, M.
    VALUE IN HEALTH, 2024, 27 (06) : S78 - S78
  • [29] BUDGET IMPACT ANALYSIS IN THE UK SETTING - KNOW YOUR AUDIENCE
    Guy, H.
    Lee, A.
    Murphy, D.
    VALUE IN HEALTH, 2015, 18 (07) : A689 - A689
  • [30] Photosensitivity during apremilast treatment in patients with palmoplantar psoriasis
    Soufila, K. T.
    Thakur, Vishal
    Dogra, Sunil
    Handa, Sanjeev
    Narang, Tarun
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (12) : E442 - E444
12345